Agenus Inc (AGEN) stock
AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.97−0.17 (-2.77%)
Close on Nov 20, 2026Market cap $268.77MP/E –Yield –
Agenus net income
Net income is the profit left for shareholders after every expense, interest and tax.
Agenus's net income for the twelve months ending Dec 31, 2020 was -$182.89M. For fiscal 2017 it was -$120.69M. The highest annual figure on record is -$11.32M in fiscal 2012.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | -$120.69M | – |
| FY2016 | Dec 31, 2016 | -$127.00M | – |
| FY2015 | Dec 31, 2015 | -$87.88M | – |
| FY2014 | Dec 31, 2014 | -$42.49M | – |
| FY2013 | Dec 31, 2013 | -$30.07M | – |
| FY2012 | Dec 31, 2012 | -$11.32M | – |
| FY2011 | Dec 31, 2011 | -$23.28M | – |
| FY2010 | Dec 31, 2010 | -$21.91M | – |
| FY2009 | Dec 31, 2009 | -$30.32M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | -$37.73M | – |
| Q3 FY2020 | Sep 30, 2020 | -$51.65M | – |
| Q2 FY2020 | Jun 30, 2020 | -$48.24M | – |
| Q1 FY2020 | Mar 31, 2020 | -$45.27M | -359.7% |
| Q4 FY2019 | Dec 31, 2019 | -$30.85M | – |
| Q3 FY2019 | Sep 30, 2019 | -$46.28M | – |
| Q2 FY2019 | Jun 30, 2019 | -$51.87M | – |
| Q1 FY2019 | Mar 31, 2019 | $17.44M | – |
| Q4 FY2018 | Dec 31, 2018 | -$48.85M | – |
| Q3 FY2018 | Sep 30, 2018 | -$33.73M | – |
| Q2 FY2018 | Jun 30, 2018 | -$25.20M | – |
| Q1 FY2018 | Mar 31, 2018 | -$54.26M | – |
| Q4 FY2017 | Dec 31, 2017 | -$35.04M | – |
| Q3 FY2017 | Sep 30, 2017 | -$36.84M | – |
| Q2 FY2017 | Jun 30, 2017 | -$31.71M | – |
| Q1 FY2017 | Mar 31, 2017 | -$17.10M | – |
| Q4 FY2016 | Dec 31, 2016 | -$26.12M | – |
| Q3 FY2016 | Sep 30, 2016 | -$40.77M | – |
See a number that looks wrong?